Botanix Pharmaceuticals
id:
botanix-pharmaceuticals-302-5318164
title:
Botanix Pharmaceuticals
text:
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which
brand slug:
wiki
category slug:
encyclopedia
description:
Australian pharmaceutical company
original url:
https://en.wikipedia.org/wiki/Botanix_Pharmaceuticals
date created:
date modified:
2023-04-18T13:42:12Z
main entity:
{"identifier":"Q17001552","url":"https://www.wikidata.org/entity/Q17001552"}
image:
fields total:
13
integrity:
14